NL-OMON43870
Completed
Not Applicable
Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (PRESANO trial) - PRESANO trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- carcinoma of the oesophagus
- Sponsor
- Erasmus MC, Universitair Medisch Centrum Rotterdam
- Enrollment
- 215
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Planned to undergo neoadjuvant chemoradiotherapy according to CROSS, followed by surgical resection for histologically proven oesophageal squamous cell carcinoma or adenocarcinoma
- •\- Age \>\= 18
- •\- Written, voluntary informed consent
Exclusion Criteria
- •\- Dementia or altered mental status prohibiting the understanding and giving of informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Response evaluation after neoadjuvant chemotherapy for muscle invasive bladder cancerNL-OMON25664ot applicable180
Completed
Not Applicable
The accuracy of detecting residual disease following neo-adjuvant chemotherapy in patients with muscle-invasive bladder cancerBladder cancerMuscle invasive urothelial cell carcinoma of the bladder10004994NL-OMON50035Vrije Universiteit Medisch Centrum180
Completed
Not Applicable
Pre-Surgery If Needed for Oesophageal CancerEsophageal CancerNCT03937362Shanghai Chest Hospital200
Not yet recruiting
Not Applicable
Retrospective study of the diagnostic accuracy of CT scan in evaluation of resectability of Boderline resectable pancareatic cancer after neoadjuvant S-1 and concurrent radiotherapyBorderline resectable pancreatic cancerJPRN-UMIN000029166ational Cancer Centor Japan53
Completed
Not Applicable
Diagnostic Accuracy and Prognostic Value of Relative Apical Sparing in Cardiac Amyloidosis: A Systematic Review and Meta-Analysiscardiac amyloidosisJPRN-UMIN000053051Hospital of University of Occupational and Environmental Health, School of Medicine1,000